blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2586434

EP2586434 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors [Right-click to bookmark this link]
StatusThe patent has been limited
Status updated on  04.03.2022
Database last updated on 20.09.2024
FormerNo opposition filed within time limit
Status updated on  03.03.2017
Most recent event   Tooltip28.10.2022Lapse of the patent in a contracting state
New state(s): AT, CZ
published on 30.11.2022  [2022/48]
Applicant(s)For all designated states
The Johns Hopkins University
3400 North Charles Street
Baltimore, MD 21218 / US
For all designated states
Cardioxyl Pharmaceuticals, Inc.
1450 Raleigh Rd., Suite 212
Chapel Hill, NC 27517 / US
[2016/06]
Former [2015/43]For all designated states
Johns Hopkins University School of Medicine
The Johns Hopkins University 100 North Charles Street, 5th Floor
Baltimore, MD 21201 / US
For all designated states
Cardioxyl Pharmaceuticals, Inc.
1450 Raleigh Rd., Suite 212
Chapel Hill, NC 27517 / US
Former [2014/15]For all designated states
Johns Hopkins University School of Medicine
The Johns Hopkins University 100 North Charles Street, 5th Floor
Baltimore, MD 21201 / US
For all designated states
Cardioxyl Pharmaceuticals, Inc.
1450 Raleigh Rd,. Suite 212
Chapel Hill NC 27517 / US
Former [2013/18]For all designated states
Johns Hopkins University School of Medicine
The Johns Hopkins University 100 North Charles Street, 5th Floor
Baltimore, MD 21201 / US
For all designated states
Cardioxyl Pharmaceuticals, Inc.
40 York Road, Suite 501
Towson, Maryland 21204 / US
Inventor(s)01 / Toscano, John P.
18 Tree Farm Court
Glen Arm, Maryland 21057 / US
02 / Brookfield, Frederick Arthur
114 Milton Park
Abingdon Oxfordshire OX14 4SA / GB
03 / Cohen, Andrew D.
209 Prospect Ave.
Mamaroneck, New York 10543 / US
04 / Courtney, Stephen Martin
114 Milton Park
Abingdon Oxfordshire OX14 4SA / GB
05 / Frost, Lisa Marie
114 Milton Park
Abingdon Oxfordshire OX14 4SA / GB
06 / Kalish, Vincent Jacob
344 Dubois Road
Annapolis, Maryland 21401 / US
 [2016/17]
Former [2013/18]01 / Toscano, John, P.
18 Tree Farm Court
Glen Arm, Maryland 21057 / US
02 / Brookfield, Frederick, Arthur
114 Milton Park Abingdon
Oxfordshire, OX14 4SA / GB
03 / Cohen, Andrew, D.
209 Prospect Ave.
Mamaroneck, New York 10543 / US
04 / Courtney, Stephen, Martin
114 Milton Park Abingdon
Oxfordshire, OX14 4SA / GB
05 / Frost, Lisa, Marie
114 Milton Park Abingdon
Oxfordshire, OX14 4SA / GB
06 / Kalish, Vincent, Jacob
344 Dubois Road
Annapolis, Maryland 21401 / US
Representative(s)Wright, Simon Mark
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[2013/18]
Application number, filing date12195118.016.03.2007
[2013/18]
Priority number, dateUS20060783556P17.03.2006         Original published format: US 783556 P
[2013/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2586434
Date:01.05.2013
Language:EN
[2013/18]
Type: B1 Patent specification 
No.:EP2586434
Date:27.04.2016
Language:EN
[2016/17]
Type: B3 Limited patent 
No.:EP2586434
Date:06.04.2022
Language:EN
[2022/14]
Search report(s)(Supplementary) European search report - dispatched on:EP05.04.2013
ClassificationIPC:C07C311/48, C07C317/14, C07C323/67, C07D213/74, C07D261/10, C07D263/58, C07D285/125, C07D295/096, C07D307/82, C07D309/12, C07D333/62, A61K31/18, A61P9/04
[2015/35]
CPC:
C07C311/48 (EP,KR,NO,RU,US); A61K31/18 (KR,NO,RU); A61P11/00 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P43/00 (EP);
A61P7/10 (EP); A61P9/00 (EP); A61P9/04 (EP,NO);
A61P9/06 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07C317/14 (EP,NO,RU,US); C07C323/67 (EP,NO,RU,US); C07D207/36 (RU);
C07D213/74 (EP,NO,US); C07D231/18 (EP,NO,US); C07D233/84 (RU);
C07D261/10 (EP,NO,US); C07D263/58 (EP,NO,US); C07D285/125 (EP,NO,US);
C07D295/096 (EP,NO,US); C07D307/02 (RU); C07D307/82 (EP,KR,NO,US);
C07D309/12 (EP,KR,NO,US); C07D317/14 (EP,KR,NO,US); C07D333/18 (RU);
C07D333/34 (EP,NO,US); C07D333/62 (EP,KR,NO,US); Y02A50/30 (US) (-)
Former IPC [2013/18]A61K31/18, A61P9/04, C07D213/74, C07D261/10, C07D263/58, C07D285/125, C07D307/82, C07D333/62
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/17]
Former [2013/18]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:N-hydroxylsulfonamidderivate als neue physiologisch nützliche Nytroxyl-Spender[2013/18]
English:N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors[2013/18]
French:Dérivés de N-hydroxylsulfonamide en tant que nouveaux donneurs de nitroxyle physiologiquement utiles[2013/18]
Examination procedure01.11.2013Amendment by applicant (claims and/or description)
01.11.2013Examination requested  [2013/50]
17.09.2014Despatch of a communication from the examining division (Time limit: M06)
26.03.2015Reply to a communication from the examining division
25.09.2015Communication of intention to grant the patent
04.02.2016Fee for grant paid
04.02.2016Fee for publishing/printing paid
04.02.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07753345.3  / EP1998761
EP12155608.8  / EP2489350
Opposition(s)30.01.2017No opposition filed within time limit [2017/14]
Limitations:16.12.2020Date of receipt of request for limitation
 admissible
19.11.2021Communication of intention to limit the patent
25.02.2022Fee for printing patent specification after limitation
09.08.2021Despatch of a communication from the examining division (Time limit: M02)
19.10.2021Reply to a communication from the examining division
Fees paidRenewal fee
26.03.2013Renewal fee patent year 03
26.03.2013Renewal fee patent year 04
26.03.2013Renewal fee patent year 05
26.03.2013Renewal fee patent year 06
26.03.2013Renewal fee patent year 07
25.03.2014Renewal fee patent year 08
10.03.2015Renewal fee patent year 09
10.03.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.04.2016
CZ27.04.2016
NL27.04.2016
[2022/48]
Former [2022/44]NL27.04.2016
Documents cited:SearchSU186456  [ ] (LENINGRAD CHEMICAL-PHARMACEUTICAL INSTITUTE);
 [X]US3751255  (OLIVARES I, et al) [X] 12* compounds 5, 6, 9, 11 *;
 [X]US6525081  (MATSUMOTO SAICHI [JP], et al) [X] 12 * compound 3g; column 14, lines 38-48 *;
 [AD]US2004038947  (WINK DAVID A [US], et al) [AD] 1-13 * paragraph [0050]; claim 1 *;
 [X]US2005153966  (GANGLOFF ANTHONY R [US], et al) [X] 12 * paragraph [0760]; claims 1, 101, 102 *;
 [AD]US6936639  (WINK DAVID A [US], et al) [AD] 1-13 * column 4, lines 29-41; claims 1, 8, 12, 13 *;
 [XD]  - A. SCOZZAFAVA, ET AL., "Carbonic anhydrase and matrix metalloproteinase inhibitors: sulphonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both of these zinc enzymes", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, (20000913), vol. 43, no. 20, ISSN 0022-2623, pages 3677 - 3687, XP002394373 [XD] 12 * table 2; compounds 46-48 *

DOI:   http://dx.doi.org/10.1021/jm000027t
    [ ] - A. SCOZZAFAVA, ET AL., "Carbonic anhydrase and matrix metalloproteinase inhibitors: sulphonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both of these zinc enzymes", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, (20010308), vol. 44, no. 6, page 1016, XP002445147 [ ] * compounds 78, 79 *

DOI:   http://dx.doi.org/10.1021/jm0004852
 [X]  - S. BRYNES, ET AL., "Potential inhibitors of L-asparagine biosynthesis. 4. Substituted sulphonamide and sulphonylhydrazide analogues of L-asparagine", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, (197801), vol. 21, no. 1, pages 45 - 49, XP002445047 [X] 12 * compound 3a (X = H or CH2Ph);; table I *

DOI:   http://dx.doi.org/10.1021/jm00199a008
 [X]  - CAPLUS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1994:645157, XP002445149 [X] 12 * abstract *
    [ ] - F. ZANI, ET AL., "Anticrobial and genotoxic properties of quinoline derivatives", BOLLETTINO CHIMICO FARMACEUTICO, SOCIETA EDITORIALE FARMACEUTICA, MILANO, IT, (1994), vol. 133, no. 5, pages 328 - 338
 [X]  - T. SUZUKI, ET AL, "Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition and cancer cell growth inhibition of SAHA-based non-hydroxamates", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, (20050125), vol. 48, no. 4, ISSN 0022-2623, pages 1019 - 1032, XP002376722 [X] 12 * scheme 2, product of compound 60 with reagent c; page 1027, column L, line 73 - column R, line 11 *

DOI:   http://dx.doi.org/10.1021/jm049207j
 [X]  - CAPLUS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1967:85468, XP002445052 [X] 12 * abstract *
 [X]  - S BRYNES, ET AL., "Potential antitumour agents via inhibitors of L-asparagine synthetase: substituted sulphonamides and sulphonyl hydrazides related to glutamine", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, DC, US, (197811), vol. 67, no. 11, pages 1550 - 1553, XP002445048 [X] 12 * compound VIa;; table I *

DOI:   http://dx.doi.org/10.1002/jps.2600671115
by applicant   - MINCIONE, F.;; MENABUONI, L.;; BRIGANTI, F.;; MINCIONE, G.;; SCOZZAFAVA, A.;; SUPURAN, C.T. J., ENZYME INHIBITION, (1998), vol. 13, pages 267 - 284
    - SCOZZAFAVA, A.;; SUPURAN, C.T., J. MED. CHEM., (2000), vol. 43, pages 3677 - 3687
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.